Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
advice, APC, automated, bioequivalence, delete, Distinguishing, enGene, freestanding, gemcitabine, instrument, issuable, MHMD, nominal, outbreak, outsourcing, overtime, partner, PSU, reaction, reassigning, reassignment, receptive, respond, rolling, spur, sterling, straightforward, sue, unintended, Unremediated, Washington
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view